Equilis Prequenza Te

RSS

vaccine against equine influenza and tetanus in horses

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 30/09/2016

Authorisation details

Product details
Name
Equilis Prequenza Te
Agency product number
EMEA/V/C/000095
Active substance
equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93, tetanus toxoid
International non-proprietary name (INN) or common name
vaccine against equine influenza and tetanus in horses
Species
Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI05AL01
Publication details
Marketing-authorisation holder
Intervet International BV
Revision
8
Date of issue of marketing authorisation valid throughout the European Union
07/07/2005
Contact address
Intervet International B.V.
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

20/09/2016 Equilis Prequenza Te - EMEA/V/C/000095 - IA/0014/G

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Immunologicals: Equine influenza and tetanus vaccine

Therapeutic indication

Active immunisation of horses from six months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunisation against tetanus to prevent mortality.

Assessment history

How useful was this page?

Add your rating